Northern Trust Corp Precipio, Inc. Transaction History

Northern Trust Corp

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$0.98 - $1.68 $4,803 - $8,235	-4,902 Reduced 13.27%	32,047 $34,000
Q2 2021 Aug 13, 2021	BUY	$1.8 - $5.25 $7,662 - $22,349	4,257 Added 13.02%	36,949 $134,000
Q4 2020 Feb 11, 2021	BUY	$1.94 - $2.64 $12,528 - $17,049	6,458 Added 24.62%	32,692 $68,000
Q3 2020 Nov 16, 2020	BUY	$1.16 - $7.0 $30,431 - $183,638	26,234 New	26,234 $65,000

340

Ticker PRPO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 22,736,500
Market Cap $143M
Description
Precipio, Inc., a healthcare solutions company, provides diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages; HemeScreen, a suite of robust geneti...

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

Stay updated on Northern Trust Corp with notifications on news.